Drug intelligence / Profile preview

Changweitong

Development stage
Unknown
Lead developer
Hainan Tongzhou Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Changweitong is a Traditional Chinese Medicine (TCM) preparation developed by Hainan Tongzhou Pharmaceutical Co., Ltd. for the treatment of gastrointestinal disorders, including chronic gastritis and functional dyspepsia. Formulated as a capsule (Changweitong Jiaonang), it is composed of several herbal extracts such as *Aucklandia lappa*, *Corydalis yanhusuo*, *Paeonia lactiflora*, and *Coptis chinensis*. These ingredients are traditionally used to regulate gastric motility, provide analgesic relief, and exert anti-inflammatory effects on the gastric mucosa. The drug has undergone Phase 1 clinical evaluation in healthy volunteers to establish its safety, tolerability, and pharmacokinetic profile as part of the modernization and regulatory validation of TCM products in China.

Brand names
Changweitong
Other names
Changweitong JiaonangChangweitong Capsules
02

Targets

DRD (Dopamine receptors)NF-κBAMPK (Adenosine monophosphate–activated protein kinase)

Beyond the preview

Go deeper on Changweitong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Changweitong.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call